[The effect of dihydroergotoxin (Redergin tablets, 4.5 mg) on blood pressure and left ventricular function in patients with essential hypertension].
D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents; D001794:Blood Pressure / Q000187:drug effects*; D004088:Dihydroergotoxine / Q000494:pharmacology* / Q000627:therapeutic use; D004452:Echocardiography; D005260:Female; D006321:Heart / Q000187:drug effects / Q000503:physiopathology*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged
D000959:Antihypertensive Agents; D004088:Dihydroergotoxine
Ispitivanje uticaja dihidroergotoksina (Redergin tableta od 4,5 mg) na krvni pritisak i funkciju leve komore bolesnika s esencijalnom hipertenzijom.